NCT05447364View on ClinicalTrials.gov

Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

March 1, 2024

Conditions
Knee Osteoarthritis
Interventions
DRUG

Pregabalin 75mg

1 tab of Pregabalin Brillior 75 mg and 1 tab of Placebo

DRUG

Pregabalin 150mg

2 tabs of Pregabalin Brillior 75 mg

Trial Locations (1)

12120

Thammasat University Hospital, Pathum Thani

All Listed Sponsors
lead

Thammasat University

OTHER